TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
5,788,596
Share change
-1,241,635
Total reported value
$9,905,113
Price per share
$1.71
Number of holders
22
Value change
-$9,047,044
Number of buys
10
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q4 2018

As of 31 Dec 2018, TRILLIUM THERAPEUTICS INC - COM NEW was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,788,596 shares. The largest 10 holders included Matrix Capital Management Company, LP, NEA Management Company, LLC, MORGAN STANLEY, BAKER BROS. ADVISORS LP, Tekla Capital Management LLC, PLATINUM INVESTMENT MANAGEMENT LTD, Anson Funds Management LP, Artal Group S.A., Samsara BioCapital, LLC, and OXFORD ASSET MANAGEMENT LLP. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.